Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $30.6 million of Shares

Author's Avatar
GuruFocus News
12/18/2020 22:15
Article's Main Image

President & CEO of Medpace Holdings Inc (30-Year Financial, Insider Trades) August J. Troendle (insider trades) sold 216,048 shares of MEDP on 12/18/2020 at an average price of $141.85 a share. The total sale was $30.6 million.

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $5.01 billion; its shares were traded at around $140.120000 with a P/E ratio of 42.84 and P/S ratio of 5.91.

CEO Recent Trades:

  • President & CEO, 10% Owner August J. Troendle sold 216,048 shares of MEDP stock on 12/18/2020 at the average price of $141.85. The price of the stock has decreased by 1.22% since.
  • President & CEO, 10% Owner August J. Troendle sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 7.08% since.

CFO Recent Trades:

  • CFO & COO, Lab Operations Jesse J Geiger sold 4,200 shares of MEDP stock on 12/14/2020 at the average price of $142. The price of the stock has decreased by 1.32% since.

Directors and Officers Recent Trades:

  • 10% Owner Investors, Llc Medpace sold 216,048 shares of MEDP stock on 12/18/2020 at the average price of $141.85. The price of the stock has decreased by 1.22% since.
  • General Counsel & Corp. Secy. Stephen P Ewald sold 10,000 shares of MEDP stock on 12/10/2020 at the average price of $140.07. The price of the stock has increased by 0.04% since.
  • 10% Owner Investors, Llc Medpace sold 14,000 shares of MEDP stock on 12/01/2020 at the average price of $130.86. The price of the stock has increased by 7.08% since.

For the complete insider trading history of MEDP, click here

.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].